Anti-Infective Peptides Competitor Analysis- Latest Report


Naperville, IL -- (SBWire) -- 06/05/2012 --The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective peptides as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

Anti-Viral Peptides

Anti-viral peptides are used to treat infections such as HIV and AIDS, influenza incl. H5N1 strains, hepatitis C virus infections (HCV).

Anti-Bacterial Peptides

Anti-bacterial peptides are used to treat infectious diseases such as complicated skin and skin structure infections (cSSSI), gram+ and gram- infections, prevention of catheter-related infections, otitis media, gingivitis and many more.

Anti-Fungal Peptides

Anti-fungal peptides are used to treat infections such as oesophageal candidiasis, aspergillosis, oral candida infections, vaginal yeast infections and many more

The report includes a compilation of current active projects in research and development of anti-infective peptides. In addition, the report lists company-specific R&D pipelines of anti-infective peptides. Competitor projects are listed in a tabular format providing information on:

Drug Codes,
Target / Mechanism of Action,
Class of Compound,
Product Category,
R&D Stage and
additional comments with a hyperlink leading to the source of information.

To view the detailed table of contents for this report please visit:

Media Relations Contact

Web Master

View this press release online at: